Table 1.
Summary of participants and data collection.
TLE- temporal lobe epilepsy, MTS- mesial temporal sclerosis
| Participant | Age | Gender | Epilepsy | MRI | Medications | Scans | Total Wake Time/Total Scan Time (min) |
Total VSTs |
|---|---|---|---|---|---|---|---|---|
| 1 | 27 | F | left TLE | left MTS | levetiracetam | 2 | 4/13.5 | 5 |
| 2 | 33 | F | right TLE | right MTS | lamotrigine, levetiracetam | 1 | 0/10 | 8 |
| 3 | 22 | F | left TLE | left MTS | phenytoin | 4 | 8/37.5 | 19 |
| 4 | 27 | F | left TLE | left MTS | levetiracetam, phenytoin | 3 | 0/35 | 6 |
| 5 | 35 | F | right TLE | right MTS | lamotrigine, levetiracetam | 4 | 2.5/40 | 41 |
| 6 | 26 | M | none | normal | none | 4 | 12.5/40 | 74 |
| 7 | 31 | M | none | normal | none | 2 | 1.5/40 | 47 |
| Combined | 20 | 28.5/216 | 200 |